My lab works at the intersection of genomics, biophysics, and precision medicine. To do so, we develop new single-cell technologies and non-invasive molecular diagnostics methods. Our methods are then applied to a wide range of biological questions, but we currently have a focus in using these tools to predict cellular dysfunction associated with cardiovascular, metabolic, and autoimmune disorders. PROJECT OVERVIEW New Transcriptomic Methods to Investigate Cardiovascular, Metabolic, and Autoimmune Disease project (Dnr: NAISS 2023/6-68), focuses on developing novel single-cell technologies and non-invasive molecular diagnostics. We do this by integrating genomics, biophysics, and precision medicine to study disease mechanisms, particularly in type 2 and type 1 diabetes, cardiovascular disorders like myocarditis, and autoimmune diseases like systemic sclerosis. OVERVIEW OF RESOURCE REQUIREMENTS Our lab is highly focused on bioinformatics and data analysis. Hence, as of right now, there are five members in the group working with computer heavy tasks. Each of these group members analyse their own samples, from raw sequences to more complex data analysis. As our research projects are currently ongoing, data is continuously generated, and computational analyses are performed using the datasets stored in Dardel. Therefore, relocating them to a non-dynamic location is not an option for us. Moreover, all the data types and projects presented in previous sections are unpublished, meaning that data is still being produced, uploaded to Dardel and analyzed. For this reason, we request to renew our medium data storage for the next year. An overview of data generated during the last year, data management plan, and expected new data next year is found below in the abridged data management plan.